Profil
Christopher L.
Moertel is the founder of OX2 Therapeutics, Inc. where he currently holds the position of Director & Chief Medical Officer.
Postes actifs de Christopher L. Moertel
| Sociétés | Poste | Début |
|---|---|---|
OX2 Therapeutics, Inc.
 OX2 Therapeutics, Inc. Hospital/Nursing ManagementHealth Services OX2 Therapeutics, Inc. provides treatment of primary brain tumors and other central nervous system tumors. The company was founded by Michael Olin, Christopher L. Moertel and Sumant Dhawan in 2016 and is headquartered in Minneapolis, MN. | Fondateur | 01/01/2016 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
OX2 Therapeutics, Inc.
OX2 Therapeutics, Inc. Hospital/Nursing ManagementHealth Services OX2 Therapeutics, Inc. provides treatment of primary brain tumors and other central nervous system tumors. The company was founded by Michael Olin, Christopher L. Moertel and Sumant Dhawan in 2016 and is headquartered in Minneapolis, MN. | Health Services |
